Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?
Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Brian Olshansky, MD*,*,
Eliot N. Heller, MD ,
L. Brent Mitchell, MD ,
Mary Chandler, MD ,
William Slater, MD||,
Martin Green, MD¶,
Michael Brodsky, MD#,
Patrick Barrell, BS ,
H. Leon Greene, MD and the AFFIRM Investigators
* University of Iowa, Iowa City, Iowa
Bronx Lebanon Hospital Center, Bronx, New York
Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
Axio Research Corporation, Seattle, Washington
|| New York University Medical Center, New York, New York
¶ University of Ottawa, Ottawa, Ontario, Canada
# University of California Irvine, Irvine, California.

View larger version (24K):
[in a new window]
|
Figure 1 Recurrence of atrial fibrillation (Afib) and left atrial diameter. N = number of patients available for evaluation at this time point; events = number of patients experiencing atrial fibrillation recurrence by this time point; % = Kaplan-Meier estimate of cumulative atrial fibrillation recurrence rate at this time point.
|
|
|